Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients.
adherence
elderly patients
head and neck squamous cell carcinoma
survival
therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 Jan 2022
14 Jan 2022
Historique:
received:
17
12
2021
revised:
11
01
2022
accepted:
13
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
22
1
2022
Statut:
epublish
Résumé
Finding a cure may be less important than ensuring the quality of life in elderly patients with head and neck squamous cell carcinoma (HNSCC). The aim of this study was to determine predictors for adherence. Clinical and pathological data from patients ≥70 years with HNSCC (initial diagnoses 2004-2018) were investigated retrospectively. Evaluated clinical predictors included biological age (Charlson Comorbidity Index; CCI), patient health (Karnofsky Performance Status; KPS) and therapy data. A total of 1125 patients were included. The median age was 75 years, 33.1% reached CCI ≥ 6, and 53.7% reached KPS ≤ 70%. In total, 968 patients were adherent, whereas 157 were nonadherent. Nonadherent patients were significantly more often smokers (
Identifiants
pubmed: 35053585
pii: cancers14020423
doi: 10.3390/cancers14020423
pmc: PMC8774262
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Strahlenther Onkol. 2018 Oct;194(10):894-903
pubmed: 29797030
BMC Cancer. 2015 Jul 11;15:515
pubmed: 26163015
Int J Nurs Stud. 2015 Jan;52(1):5-9
pubmed: 25441757
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):748-757
pubmed: 28366580
Laryngoscope. 1997 Nov;107(11 Pt 1):1469-75
pubmed: 9369392
J Natl Cancer Inst. 1994 Dec 7;86(23):1766-70
pubmed: 7966414
J Chronic Dis. 1974 Sep;27(7-8):387-404
pubmed: 4436428
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2579-90
pubmed: 25128401
Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Sep;128(4):165-8
pubmed: 21596646
Head Neck. 2019 Dec;41(12):4128-4135
pubmed: 31512807
Cancer Treat Rev. 2009 May;35(3):237-45
pubmed: 19100689
Head Neck. 2003 Oct;25(10):808-15
pubmed: 12966504
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):357-64
pubmed: 12243808
J Clin Oncol. 2009 Jun 10;27(17):2758-65
pubmed: 19403886
Oncologist. 2013;18(5):568-78
pubmed: 23635557
Laryngoscope. 2007 May;117(5):835-40
pubmed: 17473679
Radiat Oncol. 2020 Feb 4;15(1):31
pubmed: 32019576
Eur Arch Otorhinolaryngol. 2005 Jan;262(1):21-6
pubmed: 15014947
Ann Surg Oncol. 2007 Apr;14(4):1449-57
pubmed: 17235712
Med Oncol. 2019 Jun 12;36(8):68
pubmed: 31190132
Indian J Cancer. 2019 Jul-Sep;56(3):261-266
pubmed: 31389391
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Reconstr Microsurg. 2014 Oct;30(8):523-30
pubmed: 25025506
Yonago Acta Med. 2015 Mar;58(1):9-13
pubmed: 26190892
J Clin Oncol. 2009 Apr 20;27(12):1969-75
pubmed: 19289626
Auris Nasus Larynx. 2001 Apr;28(2):161-8
pubmed: 11240324
BMC Med Inform Decis Mak. 2015 Jun 09;15:44
pubmed: 26054335
Ann Otol Rhinol Laryngol. 2012 Sep;121(9):570-5
pubmed: 23012894
Clin Oncol (R Coll Radiol). 2011 Oct;23(8):518-24
pubmed: 21550217
Medicine (Baltimore). 2021 Oct 15;100(41):e27560
pubmed: 34731158
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):767-774
pubmed: 28366573
Head Neck. 1998 May;20(3):216-23
pubmed: 9570627
Cancer. 1997 Oct 1;80(7):1326-34
pubmed: 9317187
J Surg Oncol. 2020 Jun;121(7):1058-1066
pubmed: 32153030
J Clin Oncol. 2014 Aug 20;32(24):2587-94
pubmed: 25071116
Head Neck. 2019 Jul;41(7):2410-2429
pubmed: 30737976
Front Oncol. 2021 Feb 23;10:566318
pubmed: 33708616
Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3941-3953
pubmed: 33492419
Laryngoscope. 2000 Apr;110(4):593-602
pubmed: 10764003